Trial Profile
The Effect of UrsodeoXyCholicacid (UDCA) and ezetimibe on total faecal steRol ExcreTion and plasma lipid lEvels
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Ursodeoxycholic acid (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms EXCRETE
- 29 Mar 2018 New trial record